NEW Course Announcement
In this course we will discuss:
– The performance of current screening programmes and their long-term outcomes.
– New diagnostic methods (eg genomics, proteomics, metabolomics) and their sensitivity and specificity in different populations.
– The evidence required to support the introduction of a new screening programme.
– The ethics and health economics of screening.
– How to assess and refine screening programmes.